Moderna outlines $1.5B-$2.5B 2025 revenue target with focus on 10 product approvals
Q4 2024 Management View Moderna CEO Stéphane Bancel highlighted 2024 as a year of significant progress, with revenues reaching $3.2 billion. The company reduced operating expenses by $2.6 billion and ...
Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Guide Disappoints
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...
DexCom signals 14% revenue growth target for 2025 with new product launches and expanded coverage
Q4 2024 Management View Kevin Sayer, CEO, highlighted that Q4 2024 organic revenue growth was 8%, contributing to a full-year organic growth of 12%, aligned with guidance. The company ended 2024 with ...
Oatly outlines 2025 profit growth targets with 2%-4% revenue increase and $5M-$15M EBITDA goal
Guidance for 2025 revenue growth of 2%-4% represents a shift from the prior quarter’s projection of 6%-10% growth for 2024, reflecting sourcing changes with a key U.S. customer. Adjusted EBITDA ...
monday.com targets $942M-$948M FY'24 revenue amid strong CRM and AI momentum
CFO Eliran Glazer reported a stable net dollar retention rate of 110% for Q1 2024 and attributed $25 million in anticipated revenue for FY 2024 to pricing adjustments. He confirmed a gross margin of ...